Bishal Gyawali, MD, PhD, Advisory Board Member

Bishal Gyawali, MD, PhD, GRACE Advisory Board Member
Brigham and Women's Hospital, Queen’s University Cancer Research Institute, Kingston
GRACE Advisory Board Member
Research Fellow at Brigham and Women's Hospital, Medical Oncologist, Assistant Professor, and scientist in the Division of Cancer Care and Epidemiology

Brigham and Women's Hospital




MD,PhD. Med Onc. Asst. Professor @QueensUHealth. Scientist @QueensCRI.

Affiliated faculty @portal_research. Advocate of #cancergroundshot.  No #FCOI.

Dr Gyawali is a medical oncologist with work experience in various low- and high- income countries. He graduated medical school in Nepal with seven gold medals and received his PhD from Nagoya University, Japan as a MEXT scholar. He then practiced as a medical oncologist at Civil Service Hospital, Kathmandu, Nepal. He currently works as a medical oncologist and scientist in the Division of Cancer Care and Epidemiology at the Queen’s University Cancer Research Institute in Kingston, Ontario, Canada, where he is also an Assistant Professor of Public Health Sciences. He was a research fellow at PORTAL from 2018-2019.

He also serves as a medical consultant for the not-for-profit Anticancer Fund, Belgium, and as editorial board member for the Journal of Global Oncology and ecancer. His clinical and research interests include cancer policy, global oncology, evidence-based oncology, financial toxicities of cancer treatment, clinical trial methods, and supportive care. Dr. Gyawali is an advocate of the "cancer groundshot,"  a term he coined to imply that research investment should be made on known high-value interventions in cancer care that are affordable and easy to implement globally. Dr. Gyawali is active in the oncology and clinical research communities on Twitter: @oncology_bg